Cerebrospinal fluid and serum markers of inflammation in autism. - Wikidata - wikimedia - TriplyDB

Cerebrospinal fluid and serum markers of inflammation in autism.

Cerebrospinal fluid and serum markers of inflammation in autism.

http://www.wikidata.org/entity/Q34448021

about

Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism The Neuropathology of Autism Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition Relevance of Neuroinflammation and Encephalitis in Autism Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence The promise of multi-omics and clinical data integration to identify and target personalized healthcare approaches in autism spectrum disorders Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications Neuroinflammation in Autism: Plausible Role of Maternal Inflammation, Dietary Omega 3, and Microbiota Can probiotics benefit children with autism spectrum disorders?A study of nuclear transcription factor-kappa B in childhood autism Regional susceptibility to TNF-α induction of murine brain inflammation via classical IKK/NF-κB signalling Association of maternal exposure to childhood abuse with elevated risk for autism in offspring.Chemokine expression patterns in the systemic and genital tract compartments are associated with HIV-1 infection in women from Benin.Increase of cytosolic phospholipase A2 as hydrolytic enzyme of phospholipids and autism cognitive, social and sensory dysfunction severity.Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders.Neurotensin is increased in serum of young children with autistic disorder Levels of soluble platelet endothelial cell adhesion molecule-1 and P-selectin are decreased in children with autism spectrum disorder.Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders.Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8.Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.Autism, asthma, inflammation, and the hygiene hypothesis Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes Autism: an emerging 'neuroimmune disorder' in search of therapy.Maternal infection and white matter toxicity.Similarities in features of autism and asthma and a possible link to acetaminophen use Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2(+/-) mice, using liquid chromatography-tandem mass spectrometry.Maternal exposure to intimate partner abuse before birth is associated with autism spectrum disorder in offspring Etiology of autistic features: the persisting neurotoxic effects of propionic acid Reduced activity of protein kinase C in the frontal cortex of subjects with regressive autism: relationship with developmental abnormalities Evidence of microglial activation in autism and its possible role in brain underconnectivity The HIV-1 transgenic rat model of neuroHIV.Transforming growth factor beta 1 869T/C and 915G/C polymorphisms and risk of autism spectrum disorders Mental health comorbidity in patients with atopic dermatitis.Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder Comorbidity in Atopic Dermatitis.The power and promise of identifying autism early: insights from the search for clinical and biological markers.Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism.

P2860

Q22241227-653876F9-C632-4B18-9BDF-99F8AF8F867F Q22242302-F5011F88-D1F3-4541-8FD8-EE9745EE512D Q26746354-07D9A567-8924-40BF-828E-7B9E8E933216 Q26770325-13B8AD2B-EC39-4B86-ABA0-D7F54DB483E9 Q26772834-5896AE4F-EE61-4CF4-9791-53891A4182EA Q26864652-06287F69-7307-4A03-9566-A0AFA36879FB Q27005952-0832B70E-122C-40EC-963A-51442FFF18DB Q27014201-AF5405C6-1DB3-4C99-A4BC-D907EC757013 Q27928004-0698B945-96E6-4D9A-A8A9-6B1C13099451 Q28076833-F6121D05-357C-4DEB-90BD-07B61B330B01 Q28478093-98472D17-EC6D-4079-9DEC-3CBA4EAC74A5 Q28728634-00AABAE5-12BF-4186-A49C-CD03BB9C9E48 Q33800078-0C60CDC0-64A7-4C5C-ABF7-877E4F63CF29 Q33903477-9C88E1BA-C4FE-42BA-A4AF-8889C40E6675 Q33916678-97B6AB1D-DF49-4C2E-9731-8B23C1BBFB3D Q33925249-319DD898-F6FC-4F54-A2B6-14AD055B2B4A Q34114124-81A2BB1D-1310-4C6B-941C-C291789190C1 Q34282952-1E580C9A-5D8A-4B73-8445-2AA375A2EF4F Q34309180-E580CDD0-0B34-43ED-8122-F50B2F9A2BA0 Q34339838-07176961-A759-4E40-98FB-EEA9B1332805 Q34348399-1D3B298C-2E39-4C95-B379-ED0F65F4AA4E Q34616361-F319A1D2-C56B-4132-865D-047F3761E337 Q34645392-4ED0718D-770D-4A21-81D2-1790987853C4 Q34818778-E92E4C90-8689-45E1-B305-82804C866AE3 Q34994653-B3F752AB-A481-4597-9DA3-DF5900F505A1 Q35069372-ACA76424-9838-4465-A890-34FB5AFFBAF7 Q35682240-9F8CD7FA-8FE8-4402-B81F-3F3E6FA7AA7D Q35757725-B2394DC7-5C29-4442-A493-80E939383349 Q36131465-535E29E7-4682-449F-A7D7-FE79D0925852 Q36161978-4CA816DF-20DA-4839-A5A0-C798EA52B1AE Q36181687-03B7B12B-360A-481E-8BB1-D67D0A7BE5F8 Q36205558-1CCF4241-E0C9-4AE8-AE9D-00A4BF48409A Q36470335-076A34BA-B91E-4BCD-8C26-4A49580761C5 Q36578522-6AB35DE1-6D04-41C0-9ED1-D4510BB763DE Q36589480-7268D299-68B8-45F5-B34E-D3E7F61C4B82 Q36590438-A60D817E-F9D8-4C55-8414-CD261EFEE0ED Q36741348-CBA045CA-ADF9-4273-9F70-99C9E3F0DD45 Q36899783-D4BB0727-7FF5-476C-8673-011B995A19EC Q36915940-D567E0E5-D723-4E29-809D-4C0FDE185CE0 Q37029453-1F3AA6B2-9D80-4047-9AB7-96EC6E5B1E66

P2860

Cerebrospinal fluid and serum markers of inflammation in autism.

http://www.wikidata.org/entity/Q34448021

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Cerebrospinal fluid and serum markers of inflammation in autism.

@ast

Cerebrospinal fluid and serum markers of inflammation in autism.

@en

Cerebrospinal fluid and serum markers of inflammation in autism.

@nl

type

label

Cerebrospinal fluid and serum markers of inflammation in autism.

@ast

Cerebrospinal fluid and serum markers of inflammation in autism.

@en

Cerebrospinal fluid and serum markers of inflammation in autism.

@nl

prefLabel

Cerebrospinal fluid and serum markers of inflammation in autism.

@ast

Cerebrospinal fluid and serum markers of inflammation in autism.

@en

Cerebrospinal fluid and serum markers of inflammation in autism.

@nl

P1433

Q34448021-66A087A8-D8DD-479B-A8F7-7F2772BD820B

P1476

Q34448021-1C205DA6-A33C-4556-81D1-BCAB9D65DCC9

P2093

Q34448021-42FC89C6-1F6B-4708-BCA8-7EACDB7702D2

Q34448021-89FE276E-E3A6-49B9-ADB1-8F87ED8C83C1

Q34448021-93C8A2AB-3385-4FE5-8F3A-FD970BA580D2

Q34448021-9A3034A5-937B-4015-8AA4-2248D93B64D3

Q34448021-D18FB1AE-2376-48C4-B3AD-DAC4083CA4C2

Q34448021-EA7CD238-6678-4D4C-AC18-ACA53A6115EF

Q34448021-F5C7EF57-1C8F-4AD2-BCAF-A50C669D4513

P304

Q34448021-3C0F4A29-6844-4F6E-B264-8C7EFECC44D6

P31

Q34448021-B335B447-9B48-4079-83DA-CDD19DF75F5C

P356

Q34448021-3E45DCA1-93C6-4A83-AB02-ECD1AE205DFB

P433

Q34448021-64BFB640-C125-4295-96A8-71CC231F2CE6

P478

Q34448021-367FEC2C-3BA8-45AB-8294-EBDFC212DF42

P577

Q34448021-2B3AEF22-3132-4A32-AC39-52D49D625832

P698

Q34448021-214A9E23-9C87-42C0-9DCB-75A074B1FD90

P921

Q34448021-7D9C325F-BBF3-46BD-B494-487837AE69F9

Q34448021-EDDD3045-10C9-4886-A2EB-5CF6F987AE04

P356

J.PEDIATRNEUROL.2005.03.014

P1433

Pediatric Neurology

P1476

Cerebrospinal fluid and serum markers of inflammation in autism.

@en

P2093

Andrew W Zimmerman

http://www.w3.org/2001/XMLSchema#string

Angeliki Varsou

http://www.w3.org/2001/XMLSchema#string

Anne M Comi

http://www.w3.org/2001/XMLSchema#string

Harumi Jyonouchi

http://www.w3.org/2001/XMLSchema#string

Melvyn P Heyes

http://www.w3.org/2001/XMLSchema#string

Sheldon Milstien

http://www.w3.org/2001/XMLSchema#string

Susan L Connors

http://www.w3.org/2001/XMLSchema#string

P304

195-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PEDIATRNEUROL.2005.03.014

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16139734

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid